Bart Filius
Director/Board Member at
PROQR THERAPEUTICS N.V.
Net worth: 902 469 $ as of 30/08/2026
Profile
Currently, Bart Filius is President & Chief Operating Officer at Galapagos NV. Mr. Filius is also on the board of Galapagos Biotech Ltd. and ProQR Therapeutics NV. In his past career Mr. Filius held the position of Chief Financial Officer & Country Manager at Sanofi-Aventis Netherlands BV and Chief Financial Officer of Sanofi European Treasury Center SA. Mr. Filius received an undergraduate degree from Nyenrode Business Universiteit and an MBA from INSEAD.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/07/2026 | 300,000 ( 0.22% ) | 639 000 $ | 30/08/2026 | |
IDORSIA LTD. 0.02% | 30/12/2024 | 43,091 ( 0.02% ) | 263 469 $ | 30/08/2026 |
Bart Filius active positions
| Companies | Position | Start |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Director/Board Member | 20/05/2019 |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services | Director/Board Member | - |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Director/Board Member | - |
Former positions of Bart Filius
| Companies | Position | End |
|---|---|---|
| IDORSIA LTD | Director/Board Member | 05/05/2026 |
| LAKEFRONT BIOTHERAPEUTICS NV | President | 29/06/2023 |
Sanofi European Treasury Center SA
 Sanofi European Treasury Center SA Financial ConglomeratesFinance Provides financial services | Director of Finance/CFO | 30/11/2014 |
sanofi-aventis Netherlands BV | Director of Finance/CFO | 29/02/2012 |
Training of Bart Filius
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Nyenrode Business Universiteit
 Nyenrode Business Universiteit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
sanofi-aventis Netherlands BV | |
Sanofi European Treasury Center SA
Sanofi European Treasury Center SA Financial ConglomeratesFinance Provides financial services | Finance |
ProQR Therapeutics NV
 ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Idorsia Ltd.
 Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Bart Filius
